Literature DB >> 6505996

Mycobacterium kansasii pericarditis.

J A Palmer, C Watanakunakorn.   

Abstract

Entities:  

Mesh:

Year:  1984        PMID: 6505996      PMCID: PMC459942          DOI: 10.1136/thx.39.11.876

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  10 in total

1.  PHOTOCHROMOGENIC MYCOBACTERIAL PULMONARY DISEASE.

Authors:  K H PFUETZE; V O LEVAN; A F REIMANN; G S BERG; W LESTER
Journal:  Am Rev Respir Dis       Date:  1965-09

2.  Is the histopathology of nonphotochromogenic mycobacterial infections distinguishable from that caused by Mycobacterium tuberculosis?

Authors:  R F CORPE; I STERGUS
Journal:  Am Rev Respir Dis       Date:  1963-02

3.  Chemotherapy and pathology of experimental photochromogenic mycobacterial infections.

Authors:  E WOLINSKY
Journal:  Am Rev Respir Dis       Date:  1959-10

4.  Human infection with atypical acid-fast organisms; report of two cases with pathologic findings.

Authors:  V B BUHLER; A POLLAK
Journal:  Am J Clin Pathol       Date:  1953-04       Impact factor: 2.493

5.  Response to chemotherapy of pulmonary infection due to Mycobacterium kansasii.

Authors:  G D Harris; W G Johanson; D P Nicholson
Journal:  Am Rev Respir Dis       Date:  1975-07

Review 6.  Nontuberculous mycobacteria and associated diseases.

Authors:  E Wolinsky
Journal:  Am Rev Respir Dis       Date:  1979-01

7.  Infections with atypical mycobacteria. Five years' experience at the National Jewish Hospital.

Authors:  D A Fischer; W Lester; W B Schaefer
Journal:  Am Rev Respir Dis       Date:  1968-07

8.  Tuberculous pericarditis.

Authors:  J J Rooney; J A Crocco; H A Lyons
Journal:  Ann Intern Med       Date:  1970-01       Impact factor: 25.391

9.  Pulmonary infection with Mycobacterium kansasii in Wales, 1970-9: review of treatment and response.

Authors:  J Banks; A M Hunter; I A Campbell; P A Jenkins; A P Smith
Journal:  Thorax       Date:  1983-04       Impact factor: 9.139

10.  Combined vs. single-drug studies of susceptibilities of Mycobacterium kansasii to isoniazid, streptomycin, and ethambutol.

Authors:  A Y Tsang; R R Bentz; M A Schork; T M Sodeman
Journal:  Am J Clin Pathol       Date:  1978-11       Impact factor: 2.493

  10 in total
  2 in total

1.  Culture of Mycobacterium kansasii in the blood of an HIV negative patient.

Authors:  D Veale; D Fishwick; J E White; A D Gascoigne; K Gould; P A Corris
Journal:  Thorax       Date:  1993-06       Impact factor: 9.139

Review 2.  Crohn's disease and the mycobacterioses: a review and comparison of two disease entities.

Authors:  R J Chiodini
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.